Stock Comparison
ELAN vs TEVA
Elanco Animal Health and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.27B
$38.67B
P/E (TTM)
—
24.8
Forward P/E
19.3
16.0
Price/Sales
2.5
2.2
Price/Book
1.9
4.7
EV/EBITDA
21.7
16.3
Dividend Yield
—
—
Profitability
Net Margin
-4.95%
9.02%
Operating Margin
12.30%
19.20%
Return on Equity
-3.77%
21.60%
Return on Assets
1.47%
6.38%
Growth (YoY)
Revenue Growth
14.90%
2.30%
Earnings Growth
-15.40%
72.20%
Price & Risk
Beta
1.7
0.9
52-Week High
$27.72
$37.35
52-Week Low
$13.39
$14.99
Analyst Target
$29.86
$40.90
Compare ELAN and TEVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.